Table 1—

Baseline characteristics of the study population

Control subjectsCD patients
n5958
RBP-4 (mg/l)28 ± 8102 ± 30*
Age (years)62 ± 1064 ± 12
Sex (male/female)26/3335/23
Diabetic/nondiabetic29/3032/26
BMI (kg/m2)30 ± 527 ± 5*
WHR0.91 ± 0.090.96 ± 0.10*
Systolic blood pressure (mmHg)127 ± 14123 ± 22
Diastolic blood pressure (mmHg)74 ± 1071 ± 11
Creatinine (μmol/l)76 ± 16776 ± 261*
Urea (mmol/l)5.5 ± 1.519.9 ± 7.1*
GFR (ml/min)99 ± 3510 ± 4*
Parathyroid hormone (pmol/l)4.1 ± 1.622.5 ± 20.4*
Fasting glucose (mmol/l)6.51 ± 2.325.52 ± 2.19*
Fasting insulin (pmol/l)60 ± 7176 ± 110
HOMA-IR2.51 ± 2.393.39 ± 7.38
FFAs (mmol/l)0.56 ± 0.230.64 ± 0.37
Cholesterol (mmol/l)5.20 ± 1.044.41 ± 1.05*
Triglycerides (mmol/l)1.46 ± 0.812.05 ± 1.33*
Leptin (μg/l)23 ± 2352 ± 72
Adiponectin (mg/l)6.61 ± 3.8216.34 ± 11.26*
CRP (mg/l)3.63 ± 2.9413.75 ± 20.79*
  • Data are means ± SD.

  • *

    * P < 0.01 vs. control, as assessed by unpaired Student’s t test.